Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.

Autor: Olson JA Jr; Department of Surgery, Duke Comprehensive Cancer Center, Durham, NC, USA., Budd GT, Carey LA, Harris LA, Esserman LJ, Fleming GF, Marcom PK, Leight GS Jr, Giuntoli T, Commean P, Bae K, Luo J, Ellis MJ

Publikováno v: Journal of the American College of Surgeons [J Am Coll Surg] 2009 May; Vol. 208 (5), pp. 906-14; discussion 915-6.

Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma.

Autor: Safford SD; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA., Coleman RE, Gockerman JP, Moore J, Feldman JM, Leight GS Jr, Tyler DS, Olson JA Jr

Publikováno v: Surgery [Surgery] 2003 Dec; Vol. 134 (6), pp. 956-62; discussion 962-3.

The role of lymphoscintigraphy in the management of the patient with breast cancer.

Autor: Dupont EL; H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa 33612-9497, USA. dupontel@moffitt.usf.edu, Kamath VJ, Ramnath EM, Shivers SC, Cox C, Berman C, Leight GS Jr, Ross MI, Blumencranz P, Reintgen DS

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2001 May; Vol. 8 (4), pp. 354-60.

Initial experience with intraoperative PTH determinations in the surgical management of 130 consecutive cases of primary hyperparathyroidism.

Autor: Garner SC; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA., Leight GS Jr

Publikováno v: Surgery [Surgery] 1999 Dec; Vol. 126 (6), pp. 1132-7; discussion 1137-8.

Intraoperative parathyroid hormone monitoring during parathyroidectomy for secondary hyperparathyroidism.

Autor: Clary BM; Department of Surgery, DUke University Medical Center, Durham, N.C. 27710, USA., Garner SC, Leight GS Jr

Publikováno v: Surgery [Surgery] 1997 Dec; Vol. 122 (6), pp. 1034-8; discussion 1038-9.